SCHEMBL13360294

SCHEMBL13360294

CCCC(=O)N1CC(O)CC1CC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 2/20 0.43
CHRNA3 P32297 2/20 0.43
CHRNA4 P43681 2/20 0.43
CHRNB3 Q05901 2/20 0.43
CHRNA6 Q15825 2/20 0.43
ATM Q13315 1/20 0.37
PIK3CD O00329 2/20 0.35
RIPK1 Q13546 1/20 0.33
DPP4 P27487 6/20 0.32
DPP8 Q6V1X1 6/20 0.32
DPP9 Q86TI2 6/20 0.32
NPC1 O15118 2/20 0.31
RAB9A P51151 2/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
TSHR P16473 1/20 0.31
DPP7 Q9UHL4 1/20 0.30
FAP Q12884 1/20 0.30
EPHX1 P07099 1/20 0.30
EPHX2 P34913 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22099648 0.90 MEN1 (0.40) CHRNB2CHRNA3CHRNA4CHRNB3CHRNA6
SCHEMBL18750448 0.87 L3MBTL1 (0.41) MEN1KMT2ATSHR
SCHEMBL22946712 0.85 CHRNB2 (0.40) CHRNB2CHRNA3CHRNA4CHRNB3CHRNA6
SCHEMBL13360499 0.85 PIK3CD (0.39) ATMPIK3CDRIPK1DPP4DPP8
SCHEMBL20980408 0.83 CHRNB2 (0.39) CHRNB2CHRNA3CHRNA4CHRNB3CHRNA6
SCHEMBL25773997 0.82 CHRNB2 (0.38) CHRNB2CHRNA3CHRNA4CHRNB3CHRNA6
SCHEMBL13032621 0.81 MEN1 (0.41) NPC1RAB9AMEN1KMT2A
SCHEMBL22559689 0.80 CHRNB2 (0.36) CHRNB2CHRNA3CHRNA4CHRNB3CHRNA6
SCHEMBL19509762 0.80 CHRNB2 (0.36) CHRNB2CHRNA3CHRNA4CHRNB3CHRNA6
SCHEMBL2933741 0.79 ATM (0.44) ATMPIK3CDRIPK1DPP4DPP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017192820-A1 GLP-1 RECEPTOR LIGAND MOIETY CONJUGATED OLIGONUCLEOTIDES AND USES THEREOF IONIS PHARMACEUTICALS, INC. (US) 2017-11-09 WO disclosed
US-7713944-B2 Oligomers comprising activated disulfides which bind to plasma proteins and their use for delivery to cells ISIS PHARMACEUTICALS, INC. (US) 2010-05-11 US disclosed